Terms: = Bone cancer AND PAX5, Q02548, 5079, ENSG00000196092, BSAP AND Treatment
41 results:
1. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract] [Full Text] [Related]
2. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
Bastian L; Beder T; Barz MJ; Bendig S; Bartsch L; Walter W; Wolgast N; Brändl B; Rohrandt C; Hansen BT; Hartmann AM; Iben K; Das Gupta D; Denker M; Zimmermann J; Wittig M; Chitadze G; Neumann M; Schneller F; Fiedler W; Steffen B; Stelljes M; Faul C; Schwartz S; Müller FJ; Cario G; Harder L; Haferlach C; Pfeifer H; Gökbuget N; Brüggemann M; Baldus CD
Blood; 2024 Apr; 143(14):1391-1398. PubMed ID: 38153913
[TBL] [Abstract] [Full Text] [Related]
3. Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trials.
Peila R; Xue X; LaMonte MJ; Shadyab AH; Wactawski-Wende J; Jung SY; Johnson KC; Coday M; Richey P; Mouton CP; Saquib N; Chlebowski RT; Pan K; Michael YL; LeBoff MS; Manson JE; Rohan TE
Menopause; 2023 Sep; 30(9):898-905. PubMed ID: 37527476
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
Zhang L; Shah B; Zhang Y; Tashkandi H; Xiao W; Fernandez-Pol S; Vergara-Lluri M; Hussaini M; Song J; Lancet J; Moscinski L; Yun S; Lu CM; Medeiros LJ; Tang G
Hum Pathol; 2023 Jun; 136():1-15. PubMed ID: 36958463
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Physical Rehabilitation on bone Biomarkers in Non-Metastatic Breast cancer Women: A Systematic Review and Meta-Analysis.
de Sire A; Lippi L; Marotta N; Folli A; Calafiore D; Moalli S; Turco A; Ammendolia A; Fusco N; Invernizzi M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674436
[TBL] [Abstract] [Full Text] [Related]
6. Phase I Study of Niraparib in Combination with Radium-223 for the treatment of Metastatic Castrate-Resistant Prostate cancer.
Quinn Z; Leiby B; Sonpavde G; Choudhury AD; Sweeney C; Einstein D; Szmulewitz R; Sartor O; Knudsen K; Yang ES; Kelly WK
Clin Cancer Res; 2023 Jan; 29(1):50-59. PubMed ID: 36321991
[TBL] [Abstract] [Full Text] [Related]
7. Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis.
Tsuyuki Y; Kohno K; Inagaki Y; Sakai Y; Kosugi H; Takahashi E; Suzuki Y; Shimada S; Kato S; Takahara T; Satou A; Shimoyama Y; Nakamura S; Asano N; Sakakibara A
J Clin Exp Hematop; 2021; 61(3):173-179. PubMed ID: 34511545
[TBL] [Abstract] [Full Text] [Related]
8. Primary Hodgkin's Lymphoma of bone in 7-year-old- an exceptional case report of youngest child in literature.
Siddiqui DE; Akbar HF; Sadiq H; Iftikhar N; Khan MR; Raza MR
Cancer Treat Res Commun; 2021; 29():100448. PubMed ID: 34488186
[TBL] [Abstract] [Full Text] [Related]
9. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
[TBL] [Abstract] [Full Text] [Related]
10. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary cancer Center.
Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
[TBL] [Abstract] [Full Text] [Related]
11. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
12. A novel pax5 rearrangement in TCF3-PBX1 acute lymphoblastic leukemia: a case report.
Barbosa TC; Lopes BA; Blunck CB; Mansur MB; Deyl AVS; Emerenciano M; Pombo-de-Oliveira MS
BMC Med Genomics; 2018 Dec; 11(1):122. PubMed ID: 30563523
[TBL] [Abstract] [Full Text] [Related]
13. bone Marrow Molecular Markers Associated with Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
Wang D; Liu P; Zhang Y; Liu HY; Shen D; Che YQ
Biomed Res Int; 2018; 2018():1042597. PubMed ID: 30534553
[TBL] [Abstract] [Full Text] [Related]
14. Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial.
Dieli-Conwright CM; Courneya KS; Demark-Wahnefried W; Sami N; Lee K; Sweeney FC; Stewart C; Buchanan TA; Spicer D; Tripathy D; Bernstein L; Mortimer JE
Breast Cancer Res; 2018 Oct; 20(1):124. PubMed ID: 30340503
[TBL] [Abstract] [Full Text] [Related]
15. Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.
Nagaharu K; Masuya M; Kageyama Y; Yamaguchi T; Ito R; Kawakami K; Ito M; Katayama N
J Med Case Rep; 2018 May; 12(1):151. PubMed ID: 29843820
[TBL] [Abstract] [Full Text] [Related]
16. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract] [Full Text] [Related]
17. A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [
Vaishampayan UN; Tehrani OS; Lawhorn-Crews JM; Heilbrun LK; Dobson K; Smith D; Dickow B; Shields AF
Mol Imaging Biol; 2017 Dec; 19(6):810-816. PubMed ID: 28289967
[TBL] [Abstract] [Full Text] [Related]
18. Genomic analysis of adult B-ALL identifies potential markers of shorter survival.
Patel S; Mason CC; Glenn MJ; Paxton CN; South ST; Cessna MH; Asch J; Cobain EF; Bixby DL; Smith LB; Reshmi S; Gastier-Foster JM; Schiffman JD; Miles RR
Leuk Res; 2017 May; 56():44-51. PubMed ID: 28193567
[TBL] [Abstract] [Full Text] [Related]
19. Long-Term Survival of Primary Intracranial Plasmablastic Lymphoma: Case Report and Review of the Literature.
Ma H; Wei MH; Qin HM; Wang GY; Hu ZC
World Neurosurg; 2017 Jan; 97():750.e5-750.e10. PubMed ID: 27794513
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.
Griffith M; Griffith OL; Krysiak K; Skidmore ZL; Christopher MJ; Klco JM; Ramu A; Lamprecht TL; Wagner AH; Campbell KM; Lesurf R; Hundal J; Zhang J; Spies NC; Ainscough BJ; Larson DE; Heath SE; Fronick C; O'Laughlin S; Fulton RS; Magrini V; McGrath S; Smith SM; Miller CA; Maher CA; Payton JE; Walker JR; Eldred JM; Walter MJ; Link DC; Graubert TA; Westervelt P; Kulkarni S; DiPersio JF; Mardis ER; Wilson RK; Ley TJ
Exp Hematol; 2016 Jul; 44(7):603-13. PubMed ID: 27181063
[TBL] [Abstract] [Full Text] [Related]
[Next]
